News
03-26-2024, 11:11 AM
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.
More... (https://www.news-medical.net/news/20240326/UC-researchers-open-Phase-2-clinical-trial-to-test-new-combination-treatment-for-glioblastomas.aspx)
More... (https://www.news-medical.net/news/20240326/UC-researchers-open-Phase-2-clinical-trial-to-test-new-combination-treatment-for-glioblastomas.aspx)